340 related articles for article (PubMed ID: 15117826)
1. Chronic production of angiotensin IV in the brain leads to hypertension that is reversible with an angiotensin II AT1 receptor antagonist.
Lochard N; Thibault G; Silversides DW; Touyz RM; Reudelhuber TL
Circ Res; 2004 Jun; 94(11):1451-7. PubMed ID: 15117826
[TBL] [Abstract][Full Text] [Related]
2. Differential kinetics of circulating angiotensin IV and II after treatment with angiotensin II type 1 receptor antagonist and their plasma levels in patients with chronic renal failure.
Shibasaki Y; Mori Y; Tsutumi Y; Masaki H; Sakamoto K; Murasawa S; Maruyama K; Moriguchi Y; Tanaka Y; Iwasaka T; Inada M; Matsubara H
Clin Nephrol; 1999 Feb; 51(2):83-91. PubMed ID: 10069643
[TBL] [Abstract][Full Text] [Related]
3. Renin-angiotensin system and myocardial collagen matrix: modulation of cardiac fibroblast function by angiotensin II type 1 receptor antagonism.
Brilla CG; Scheer C; Rupp H
J Hypertens Suppl; 1997 Dec; 15(6):S13-9. PubMed ID: 9493122
[TBL] [Abstract][Full Text] [Related]
4. Genetic clamping of renin gene expression induces hypertension and elevation of intrarenal Ang II levels of graded severity in Cyp1a1-Ren2 transgenic rats.
Mitchell KD; Bagatell SJ; Miller CS; Mouton CR; Seth DM; Mullins JJ
J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7(2):74-86. PubMed ID: 17083061
[TBL] [Abstract][Full Text] [Related]
5. Brain and peripheral angiotensin II type 1 receptors mediate renal vasoconstrictor and blood pressure responses to angiotensin IV in the rat.
Yang R; Smolders I; De Bundel D; Fouyn R; Halberg M; Demaegdt H; Vanderheyden P; Dupont AG
J Hypertens; 2008 May; 26(5):998-1007. PubMed ID: 18398343
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of angiotensin II is required for its in vivo effect on dopamine release in the striatum of the rat.
Stragier B; Sarre S; Vanderheyden P; Vauquelin G; Fournié-Zaluski MC; Ebinger G; Michotte Y
J Neurochem; 2004 Sep; 90(5):1251-7. PubMed ID: 15312180
[TBL] [Abstract][Full Text] [Related]
7. Renal vasoconstrictor and pressor responses to angiotensin IV in mice are AT1a-receptor mediated.
Yang R; Walther T; Gembardt F; Smolders I; Vanderheyden P; Albiston AL; Chai SY; Dupont AG
J Hypertens; 2010 Mar; 28(3):487-94. PubMed ID: 19907343
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotection against retinal ischemia-reperfusion injury by blocking the angiotensin II type 1 receptor.
Fukuda K; Hirooka K; Mizote M; Nakamura T; Itano T; Shiraga F
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3629-38. PubMed ID: 20164447
[TBL] [Abstract][Full Text] [Related]
9. Ligand binding and functional properties of human angiotensin AT1 receptors in transiently and stably expressed CHO-K1 cells.
Le MT; De Backer JP; Hunyady L; Vanderheyden PM; Vauquelin G
Eur J Pharmacol; 2005 Apr; 513(1-2):35-45. PubMed ID: 15878707
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the long-term effects of candesartan and olmesartan on plasma angiotensin II and left ventricular mass index in patients with hypertension.
Tsutamoto T; Nishiyama K; Yamaji M; Kawahara C; Fujii M; Yamamoto T; Horie M
Hypertens Res; 2010 Feb; 33(2):118-22. PubMed ID: 19927151
[TBL] [Abstract][Full Text] [Related]
11. Vascular angiotensin II receptor and calcium signaling in toadfish.
Qin ZL; Yan HQ; Nishimura H
Gen Comp Endocrinol; 1999 Jul; 115(1):122-31. PubMed ID: 10375471
[TBL] [Abstract][Full Text] [Related]
12. Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects.
Masaki H; Kurihara T; Yamaki A; Inomata N; Nozawa Y; Mori Y; Murasawa S; Kizima K; Maruyama K; Horiuchi M; Dzau VJ; Takahashi H; Iwasaka T; Inada M; Matsubara H
J Clin Invest; 1998 Feb; 101(3):527-35. PubMed ID: 9449684
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II-induced genomic damage in renal cells can be prevented by angiotensin II type 1 receptor blockage or radical scavenging.
Schupp N; Schmid U; Rutkowski P; Lakner U; Kanase N; Heidland A; Stopper H
Am J Physiol Renal Physiol; 2007 May; 292(5):F1427-34. PubMed ID: 17229674
[TBL] [Abstract][Full Text] [Related]
14. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II upregulates acyl-CoA:cholesterol acyltransferase-1 via the angiotensin II Type 1 receptor in human monocyte-macrophages.
Kanome T; Watanabe T; Nishio K; Takahashi K; Hongo S; Miyazaki A
Hypertens Res; 2008 Sep; 31(9):1801-10. PubMed ID: 18971559
[TBL] [Abstract][Full Text] [Related]
16. Adrenal angiotensin: origin and site of generation.
van Kats JP; Chai W; Duncker DJ; Schalekamp MA; Danser AH
Am J Hypertens; 2005 Aug; 18(8):1104-10. PubMed ID: 16109325
[TBL] [Abstract][Full Text] [Related]
17. Renin-angiotensin blockade improves renal cGMP production via non-AT(2)-receptor mediated mechanisms in hypertension-induced by chronic NOS inhibition in rat.
Uhlenius N; Vuolteenaho O; Tikkanen I
J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):233-9. PubMed ID: 11881129
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II receptors are expressed and functional in human esophageal mucosa.
Casselbrant A; Edebo A; Hallersund P; Spak E; Helander HF; Jönson C; Fändriks L
Am J Physiol Gastrointest Liver Physiol; 2009 Nov; 297(5):G1019-27. PubMed ID: 19779016
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II type 1 receptor-EGF receptor cross-talk regulates ureteric bud branching morphogenesis.
Yosypiv IV; Schroeder M; El-Dahr SS
J Am Soc Nephrol; 2006 Apr; 17(4):1005-14. PubMed ID: 16495379
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II stimulates the release of interleukin-6 and interleukin-8 from cultured human adipocytes by activation of NF-kappaB.
Skurk T; van Harmelen V; Hauner H
Arterioscler Thromb Vasc Biol; 2004 Jul; 24(7):1199-203. PubMed ID: 15130920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
